Northwest Biotherapeutics Inc
NWBO· OTC
NWBONorthwest Biotherapeutics Inc
Filed Mar 16, 2016 · 10-K · 76 days after period end · 0001144204-16-088301
| Metric | Q4 2015 | Q4 2014 | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures |
|---|---|---|---|---|
| Revenue | $863.00K | $872.00K | $0.00 | $322.00K |
| Net Income | -$24.08M | -$42.69M | -$16.89M | -$30.52M |
| EPS Diluted | -$0.27 | -$0.64 | — | — |
Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2015 · filed Mar 16, 2016 · 76 d after period end
